Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

MSF Staff conducting a health promotion workshop to raise awareness amongst students about Hepatitis C. Photograph by Sa'adia Khan
Press release
Press release |
13 April 2016
Hepatitis C

MSF responds to DNDi hepatitis C announcement

2 min
XDR-TB patient Winile listens as Tengetile Ntsele, MSF Mobile Counsellor, discusses her treatment progress and advises on the management of side effects. Mankayane area, Manzini Region, Swaziland. Photograph by Alexis Huguet
Press release
Press release |
12 April 2016
Intellectual property and trade

MSF response to WIPO report on WHO EML

4 min
Metro advertisements for Doctors Without Borders Photograph by Drew Angerer
Press release
Press release |
12 April 2016
Intellectual property and trade

More than 50 groups call on U.S. Congress to stop worst trade deal ever for access to affordable medicines

3 min
MSF provides ambulatory and door to door testing for HIV. This man was born with aids, he led a normal life thanks to his medicine until he got to the university. People made fun of him for taking pills, so he stopped taking them. He his now deaf and blind. His uncle communicates with him by writting on his arm. Photograph by Guillaume Binet
Press release
Press release |
01 April 2016

Médecins Sans Frontières (MSF) reaction to the United Nations Secretary General Report on HIV/AIDS ahead of the June UN High Level Meeting on HIV

2 min
Nearly 2,000 People Living With HIV along with MSF & other civil society organisations rallied in the streets of New Delhi at the start of the EU-India summit. They warned that harmful provisions in a trade deal being negotiated between the EU and India could severely hinder access to affordable medicine for people in developing countries. Photograph by Siddharth Singh
Press release
Press release |
29 March 2016
Intellectual property and trade
European UnionIndia

At EU-India Summit, India must defend its ‘pharmacy of the developing world’

A Medecins Sans Frontieres (MSF) health promoter holds a health education information session for mothers in Aragata village, Chhattisgarh, India. Photograph by MSF
Press release
Press release |
24 March 2016
India

MSF responds to Indian Health Ministry’s notification on ban of 344 Fixed Dose Combinations Drugs

2 min
PEP Drugs for children at Angau Memorial General Hospital, Lae/ Morobe Province in Papua New Guinea. The MSF Family Support Centre provides medical and psychological services for survivors of child abuse, sexual and intimate partner violence. MSF started providing care at the centre in November 2007. Photograph by Fiona Morris
Press release
Press release |
23 March 2016
Intellectual property and trade
India

MSF welcomes Ministry of Commerce clarification on compulsory licensing: warns US pressure on India will continue

3 min
MSF149387
Press release
Press release |
21 March 2016
Tuberculosis

Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury